Inovio Pharmaceuticals, Inc. (INO)
1.25
+0.07
(+5.93%)
USD |
NASDAQ |
Aug 24, 16:00
1.23
-0.02
(-1.60%)
After-Hours: 20:00
Inovio Pharmaceuticals EPS Diluted (Quarterly) : -0.0737 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0737 |
| March 31, 2026 | -0.2848 |
| December 31, 2025 | 0.0546 |
| September 30, 2025 | -0.8721 |
| June 30, 2025 | -0.6057 |
| March 31, 2025 | -0.51 |
| December 31, 2024 | -0.5971 |
| September 30, 2024 | -0.8943 |
| June 30, 2024 | -1.185 |
| March 31, 2024 | -1.308 |
| December 31, 2023 | -1.097 |
| September 30, 2023 | -1.516 |
| June 30, 2023 | -1.613 |
| March 31, 2023 | -1.888 |
| December 31, 2022 | -2.546 |
| September 30, 2022 | -1.818 |
| June 30, 2022 | -5.534 |
| March 31, 2022 | -4.334 |
| December 31, 2021 | -6.00 |
| September 30, 2021 | -3.433 |
| June 30, 2021 | -4.704 |
| March 31, 2021 | -3.225 |
| December 31, 2020 | -1.563 |
| September 30, 2020 | 1.319 |
| June 30, 2020 | -9.912 |
| Date | Value |
|---|---|
| March 31, 2020 | -3.133 |
| December 31, 2019 | -4.56 |
| September 30, 2019 | -2.949 |
| June 30, 2019 | -3.595 |
| March 31, 2019 | -3.596 |
| December 31, 2018 | -4.166 |
| September 30, 2018 | -3.248 |
| June 30, 2018 | -0.96 |
| March 31, 2018 | -4.292 |
| December 31, 2017 | -2.88 |
| September 30, 2017 | -4.68 |
| June 30, 2017 | -1.56 |
| March 31, 2017 | -3.72 |
| December 31, 2016 | -4.250 |
| September 30, 2016 | -3.36 |
| June 30, 2016 | -3.12 |
| March 31, 2016 | -1.32 |
| December 31, 2015 | -3.00 |
| September 30, 2015 | 0.84 |
| June 30, 2015 | -1.08 |
| March 31, 2015 | -2.16 |
| December 31, 2014 | -1.44 |
| September 30, 2014 | -1.44 |
| June 30, 2014 | -2.125 |
| March 31, 2014 | -2.40 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Fortress Biotech, Inc. | -0.0779 |
| Tonix Pharmaceuticals Holding Corp. | -2.438 |
| Kura Oncology, Inc. | -0.769 |
| Spero Therapeutics, Inc. | -0.1648 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.012M |
| Total Expenses (Quarterly) | 6.012M |
| Enterprise Value | 74.26M |
| Earnings Yield | -94.08% |
| Normalized Earnings Yield | -100.33 |